147 related articles for article (PubMed ID: 26093163)
1. Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Kan QC; Pan QX; Zhang XJ; Chu YJ; Liu N; Lv P; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Oct; 99(2):212-9. PubMed ID: 26093163
[TBL] [Abstract][Full Text] [Related]
2. Matrine protects neuro-axon from CNS inflammation-induced injury.
Kan QC; Lv P; Zhang XJ; Xu YM; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Feb; 98(1):124-30. PubMed ID: 25576296
[TBL] [Abstract][Full Text] [Related]
3. Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Kan QC; Zhang S; Xu YM; Zhang GX; Zhu L
Neurosci Lett; 2014 Feb; 560():92-7. PubMed ID: 24368216
[TBL] [Abstract][Full Text] [Related]
4. Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.
Zhao X; Zhang X; Lv Y; Xu Y; Li M; Pan Q; Chu Y; Liu N; Zhang GX; Zhu L
Immunol Lett; 2016 Oct; 178():97-104. PubMed ID: 27562326
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis.
Liu N; Kan QC; Zhang XJ; Xv YM; Zhang S; Zhang GX; Zhu L
Exp Mol Pathol; 2014 Dec; 97(3):470-6. PubMed ID: 25303900
[TBL] [Abstract][Full Text] [Related]
6. Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis.
Kan QC; Zhang HJ; Zhang Y; Li X; Xu YM; Thome R; Zhang ML; Liu N; Chu YJ; Zhang GX; Zhu L
Mol Neurobiol; 2017 Dec; 54(10):8404-8418. PubMed ID: 27933584
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis.
Chu Y; Jing Y; Zhao X; Wang M; Zhang M; Ma R; Ma W; Lv Y; Zhu L
J Neuroimmunol; 2021 Mar; 352():577480. PubMed ID: 33493985
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling.
Zhu L; Pan QX; Zhang XJ; Xu YM; Chu YJ; Liu N; Lv P; Zhang GX; Kan QC
Exp Mol Pathol; 2016 Apr; 100(2):337-43. PubMed ID: 26681653
[TBL] [Abstract][Full Text] [Related]
9. Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.
Ma W; Zhang M; Liu S; Wang M; Shi Y; Yang T; Li X; Zhu L
Neurosci Lett; 2020 Jan; 715():134599. PubMed ID: 31722234
[TBL] [Abstract][Full Text] [Related]
10. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
11. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
12. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Kan QC; Zhu L; Liu N; Zhang GX
Immunol Res; 2013 May; 56(1):189-96. PubMed ID: 23549837
[TBL] [Abstract][Full Text] [Related]
13. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
14. Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis.
Zhao X; Kan Q; Zhu L; Zhang GX
Am J Chin Med; 2011; 39(5):933-41. PubMed ID: 21905283
[TBL] [Abstract][Full Text] [Related]
15. Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism.
Chu YJ; Ma WD; Thome R; Ping JD; Liu FZ; Wang MR; Zhang ML; Zhang G; Zhu L
Front Immunol; 2020; 11():569530. PubMed ID: 33101289
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Zhang S; Kan QC; Xu Y; Zhang GX; Zhu L
Mediators Inflamm; 2013; 2013():736085. PubMed ID: 24194630
[TBL] [Abstract][Full Text] [Related]
17. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
18. Matrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis.
Kang J; Liu S; Song Y; Chu Y; Wang M; Shi Y; Zhang F; Zhu L
Sci Rep; 2021 May; 11(1):9520. PubMed ID: 33947942
[TBL] [Abstract][Full Text] [Related]
19. Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy.
Wang MR; Zhang XJ; Liu HC; Ma WD; Zhang ML; Zhang Y; Li X; Dou MM; Jing YL; Chu YJ; Zhu L
Brain Res Bull; 2019 Nov; 153():30-38. PubMed ID: 31404585
[TBL] [Abstract][Full Text] [Related]
20. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
